Safety and Efficacy of Allogeneic MSCs in Promoting T-regulatory Cells in Patients With Small Abdominal Aortic Aneurysms

NCT02846883 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

28

Enrollment

FED

Sponsor class

Stopped Early Termination as required by VA DSMB due to slow enrollment

Conditions

Abdominal Aortic Aneurysm

Interventions

BIOLOGICAL: 1 million MSCs/kg
BIOLOGICAL: 3 million MSCs/kg
DRUG: Placebo

Sponsor

VA Office of Research and Development